Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model

Leukemia

Volumn 25, Issue 12, 2011, Pages 1815-1824

  Canale, S ^a   Cocco, C ^a   Frasson, C ^b   Seganfreddo, E ^b   Di Carlo, E ^c   Ognio, E ^d   Sorrentino, C ^c   Ribatti, D ^e   Zorzoli, A ^a   Basso, G ^b   Dufour, C ^a   Airoldi, I ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF BARI   (Italy)

Author keywords

cytokine receptors; cytokines; pediatric acute leukemia

Indexed keywords

CD133 ANTIGEN; CD19 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 27;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; CELL SPREADING; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ADOLESCENT; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CHICKENS; CHILD; CHILD, PRESCHOOL; CHORIOALLANTOIC MEMBRANE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INTERLEUKIN-17; LEUKEMIA, B-CELL; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 83555165176     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.158     Document Type: Article

References (38)

1. Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T-cell responses. Immunity 2003; 19: 641-644. (Pubitemid 37490789)
2. Artis D, Villarino A, Silverman M, He W, Thornton EM, Mu S et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J Immunol 2004; 173: 5626-5634. (Pubitemid 39392150)
3. Feng XM, Chen XL, Liu N, Chen Z, Zhou YL, Han ZB et al. Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator. Hum Immunol 2007; 68: 965-972.
4. Villarino AV, Larkin III J, Saris CJ, Caton AJ, Lucas S, Wong T et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol 2005; 174: 7684-7691. (Pubitemid 40806273)
5. Hisada M, Kamiya S, Fujita K, Belladonna ML, Aoki T, Koyanagi Y et al. Potent antitumor activity of interleukin-27. Cancer Res 2004; 64: 1152-1156. (Pubitemid 38176923)
6. Larousserie F, Charlot P, Bardel E, Froger J, Kastelein RA, Devergne O. Differential effects of IL-27 on human B-cell subsets. J Immunol 2006; 176: 5890-5897.
7. Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, Gurney A et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000; 407: 916-920.
8. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004; 172: 2225-2231. (Pubitemid 38182370)
9. Oniki S, Nagai H, Horikawa T, Furukawa J, Belladonna ML, Yoshimoto T et al. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res 2006; 66: 6395-6404.
10. Shimizu M, Shimamura M, Owaki T, Asakawa M, Fujita K, Kudo M et al. Antiangiogenic and antitumor activities of IL-27. J Immunol 2006; 176: 7317-7324. (Pubitemid 43849032)
11. Ho MY, Leu SJ, Sun GH, Tao MH, Tang SJ, Sun KH. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities. J Immunol 2009; 183: 6217-6226.
12. Yoshimoto T, Morishima N, Mizoguchi I, Shimizu M, Nagai H, Oniki S et al. Antiproliferative activity of IL-27 on melanoma. J Immunol 2008; 180: 6527-6535.
13. Cocco C, Giuliani N, Di Carlo E, Ognio E, Storti P, Abeltino M et al. Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma. Clin Cancer Res 2010; 16: 4188-4197.
14. Pradhan A, Lambert QT, Reuther GW. Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor. Proc Natl Acad Sci USA 2007; 104: 18502-18507. (Pubitemid 350210726)
15. Carroll WL, Bhojwani D, Min DJ, Raetz E, Relling M, Davies S et al. Pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2003, 102-131.
16. Gupta PB, Chaffer CL, Weinberg RA. Cancer stem cells: mirage or reality? Nat Med 2009; 15: 1010-1012.
17. Cox CV, Diamanti P, Evely RS, Kearns PR, Blair A. Expression of CD133 on leukemia-initiating cells in childhood ALL. Blood 2009; 113: 3287-3296.
18. Basso G, Buldini B, De Zen L, Orfao A. New methodologic approaches for immunophenotyping acute leukemias. Haematologica 2001; 86: 675-692. (Pubitemid 32680993)
19. Ribatti D, Gualandris A, Bastaki M, Vacca A, Iurlaro M, Roncali L et al. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J Vasc Res 1997; 34: 455-463. (Pubitemid 28008032)
20. Airoldi I, Gri G, Marshall JD, Corcione A, Facchetti P, Guglielmino R et al. Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells. J Immunol 2000; 165: 6880-6888. (Pubitemid 32001157)
21. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673-677. (Pubitemid 46676103)
22. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838. (Pubitemid 40839735)
23. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010; 20: 589-599.
24. Agliano A, Martin-Padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G et al. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/SCID-related strains. Int J Cancer 2008; 123: 2222-2227.
25. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593-598.
26. Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R et al. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia 2010; 24: 1859-1866.
27. Craiţoiu S. The morphopathological aspects of diabetic retinopathy. Oftalmologia 1992; 36: 141-148.
28. Garner A. Histopathology of diabetic retinopathy in man. Eye (Lond) 1993; 7: 250-253. (Pubitemid 23153118)
29. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166-178. (Pubitemid 43076714)
30. Dick JE. Acute myeloid leukemia stem cells. Ann NY Acad Sci 2005; 1044: 1-5. (Pubitemid 40967588)
31. Castor A, Nilsson L, Astrand-Grundstrom I, Buitenhuis M, Ramirez C, Anderson K et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 2005; 11: 630-637. (Pubitemid 40868303)
32. Cox CV, Evely RS, Oakhill A, Pamphilon DH, Goulden NJ, Blair A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 2004; 104: 2919-2925. (Pubitemid 39434980)
33. Tili E, Croce CM, Michaille JJ. miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 2009; 28: 264-284.
34. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD et al. MicroRNA profiling reveals distinct signatures in B-cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004; 101: 11755-11760. (Pubitemid 39095368)
35. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF et al. Accumulation of miR-155 and BIC RNA in human B-cell lymphomas. Proc Natl Acad Sci USA 2005; 102: 3627-3632. (Pubitemid 40354662)
36. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004; 39: 167-169. (Pubitemid 38056091)
37. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N et al. Pre-B cell proliferation and lymphoblastic leukemia/highgrade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 2006; 103: 7024-7029.
38. Seita J, Asakawa M, Ooehara J, Takayanagi S, Morita Y, Watanabe N et al. Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood 2008; 111: 1903-1912. (Pubitemid 351451499)